A Single-Dose, Randomised, Open-Label, Two-Period Crossover Study to Determine the Bioequivalence of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in the Fed State in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 16 May 2017
Price : $35 *
At a glance
- Drugs Dutasteride/tamsulosin (Primary) ; Dutasteride; Tamsulosin
- Indications Alopecia; Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 18 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Dec 2014 Planned End Date changed from 1 Dec 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
- 18 Dec 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.